|
|
Volumn 18, Issue 7, 2009, Pages 1043-1046
|
|
Tesofensine - A novel potent weight loss medicine
|
|
Author keywords
Clinical trial; Obesity; Sibutramine; Tesofensine
|
|
Indexed keywords
ANTIOBESITY AGENT;
PLACEBO;
RIMONABANT;
SIBUTRAMINE;
TESOFENSINE;
UNCLASSIFIED DRUG;
ABDOMINAL PAIN;
ADULT;
AGED;
ANGER;
ANXIETY;
BLOOD PRESSURE;
BODY MASS;
CLINICAL TRIAL;
CONFUSION;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DOUBLE BLIND PROCEDURE;
DRUG MECHANISM;
DRUG RESPONSE;
FEMALE;
HARD FECES;
HEART PALPITATION;
HEART RATE;
HUMAN;
INSOMNIA;
MAJOR CLINICAL STUDY;
MALE;
MENTAL DISEASE;
MULTICENTER STUDY;
NAUSEA;
OBESITY;
PHASE 2 CLINICAL TRIAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
SHORT SURVEY;
SIDE EFFECT;
SLEEP DISORDER;
WAIST CIRCUMFERENCE;
WEIGHT REDUCTION;
XEROSTOMIA;
ADOLESCENT;
ADULT;
AGED;
BICYCLO COMPOUNDS, HETEROCYCLIC;
BODY COMPOSITION;
BODY MASS INDEX;
CLINICAL TRIALS, PHASE II AS TOPIC;
DOUBLE-BLIND METHOD;
HUMANS;
MIDDLE AGED;
OBESITY;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
WEIGHT LOSS;
YOUNG ADULT;
|
|
EID: 67650442032
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543780902967632 Document Type: Short Survey |
|
Times cited : (12)
|
|
References (10)
|
